Please assess the completion status of the following clinical trial:

Trial Title: Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Pre-operative Inclusion Criteria:~The subject:~* is at least 22 years of age on the date of informed consent~* is able to provide their own informed consent~* requires a TKA revision defined as one of the following:~  1. a one-stage aseptic revision procedure~ 2. a one-stage septic exchange procedure (requiring removal of all hardware) for acute postoperative infection~ 3. removal of cement spacer and re-implantation procedure~ 4. open reduction and internal fixation of peri-prosthetic fractures~* has one or more of the following:~  1. a body mass index (BMI) greater than 35 kg/m2~ 2. a requirement for the use of blood thinners other than acetylsalicylic acid (ASA) after surgery~ 3. history of or current peripheral vascular disease~ 4. the presence of lymphedema in the operative limb~ 5. insulin-dependent diabetes mellitus~ 6. current tobacco use or previous history of smoking and quitting within the past 30 days~ 7. a history of prior infection of the operative site~ 8. current use of immunomodulators or steroids~ 9. current or history of cancer or hematological malignancy (excluding localized skin cancer)~ 10. rheumatoid arthritis~ 11. current renal failure or dialysis~ 12. malnutrition as determined by the investigator~ 13. liver disease as determined by the investigator~ 14. status post solid organ transplant~ 15. HIV~* is willing and able to return for all scheduled study visits~* if female, has a negative urine or serum pregnancy test at screening and day of revision surgery. Women who have had surgical sterilization by a medically accepted method such as tubal ligation, hysterectomy, or oophorectomy or are post-menopausal, defined as not having menstruation for \>= 12 months will be excluded from requiring this test.~Intra-operative Inclusion Criteria:~The subject:~* continues to meet all pre-operative inclusion criteria~* has undergone a TKA revision resulting in a closed surgical incision~Pre-operative Exclusion Criteria:~The subject:~* is pregnant or lactating~* will undergo a bilateral TKA within the same operative visit~* will undergo a bilateral TKA in which the first TKA surgery is on the knee selected for study~* will undergo a staged bilateral TKA in which the TKA revision surgery for the knee under study occurs within 30 days of the first TKA procedure~* was previously randomized in this protocol~* has a systemic active infection at the time of revision not including chronic viral infections such as HIV or hepatitis~* has a remote-site skin infection at the time of revision~* was tattooed on the area of the incision within 30 days prior to randomization~* has known sensitivity to the study product components (drape and/or dressing materials in direct contact with the closed incision or skin)~* has known sensitivity to silver~* is currently enrolled in another investigational trial that requires additional interventions~* is planned to be enrolled in another investigational trial that requires additional interventions at any time during the study~* has localized skin cancer around the incision site~Intra-operative Exclusion Criteria:~The subject:~* is found to meet any of the pre-operative exclusion criteria~* has a surgical incision that precludes placement of dressing~* has a TKA revision resulting in a muscle flap~* has a TKA revision resulting in the placement of a spacer~* has an incision drainage and debridement procedure only~* has a surgical incision closed with skin glue

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Closed Incision Negative Pressure Therapy (ciNPT) (Type: EXPERIMENTAL): Prevena Peel \& Place or Prevena Plus Customizable Dressing and ActiVAC Therapy Unit or Prevena Plus Therapy Unit
- Standard of Care Dressing (Type: ACTIVE_COMPARATOR): Silver impregnated dressing

Based on this trial design, predict the completion outcome and termination type (if applicable).